Live Nasdaq Composite: Markets Pivot From Headlines to Q2 Earnings, Chip Stock Momentum

Investing

Incyte : INCY

All Incyte Articles

137 Articles

Jon C. Ogg | Feb 26, 2014 at 8:15 AM EST

Top Analyst Upgrades and Downgrades: LinkedIn, Safeway, NII Holdings, Rangold, EP Energy and More

These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Wednesday, February 26, 1014.…

Trey Thoelcke | Feb 12, 2014 at 6:50 AM EST

Short Sellers Shy Away From Biotechs

24/7 Wall St. has tracked the short interest in leading biotech and emerging pharmaceutical stocks. By and large, short sellers…

Paul Ausick | Feb 5, 2014 at 8:20 AM EST

Merck Earnings Fail to Dazzle, but the Company’s Story Remains Strong

Before the markets opened Wednesday morning, drug giant Merck & Co. reported fourth-quarter and full-year 2013 results that failed to…

Trey Thoelcke | Jan 29, 2014 at 8:15 AM EST

UBS Says Buy Top Biotech Stocks in Front of Earnings for Big Upside

Like many firms on Wall Street, the biotechnology team at UBS thinks that most of the top mega-cap and large…

Jon C. Ogg | Jan 14, 2014 at 8:15 AM EST

UBS Has Nine Biotech Buyout and Merger Candidates

The analysts at UBS are not only bullish on the biotechnology sector, they think there is a very distinct possibility…

Jon C. Ogg | Jan 8, 2014 at 8:10 AM EST

J.P. Morgan Top Biotechnology Stocks to Buy for 2014

Biotechnology was an incredible performer in 2013. The analysts at J.P. Morgan think that the huge outperformance may lessen going…

Jon C. Ogg | Nov 21, 2013 at 7:25 AM EST

Solid Biotech Stocks With the Best Revenue Growth for 2014

ThinkstockAny time investors look for companies growing sales the most, one area that almost always stands out is the up…

Trey Thoelcke | Oct 14, 2013 at 8:15 AM EDT

Jefferies Top Biotech Stocks to Buy

ThinkstockThe world of biotechnology investing is a constantly evolving and changing one. While disease for the most part does not…

Paul Ausick | Aug 21, 2013 at 4:24 PM EDT

Wednesday Closing Bell: Markets Open, Close Lower

August 21, 2013: Markets opened mixed this morning as traders and investors waited for the afternoon’s release of the July…

Jon C. Ogg | Jul 2, 2013 at 8:45 AM EDT

Which Biotech Stocks Are Buyout Targets After Onyx Pharmaceutical Rejects Amgen?

ThinkstockOn Friday after the market closed, biotech giant Amgen Inc. (NASDAQ: AMGN) made an unsolicited $120 per share bid for…

Paul Ausick | May 7, 2013 at 4:05 PM EDT

Closing Bell for Tuesday on Wall Street: Share Prices Push Indexes to All-Time Highs

U.S. equity markets opened higher this morning following an unexpected 0.25% cut in Australia’s key interest rate to a new…

Jon C. Ogg | May 7, 2013 at 8:35 AM EDT

Top Wall Street Analyst Downgrades: AIG, Coach, J.C. Penney and More

These are the top analyst downgrades, cautious research notes and stocks to sell from Wall Street for Tuesday, May 7,…

Jon C. Ogg | Mar 18, 2013 at 12:55 PM EDT

7 Active Trading Big Volume Spikes (CHTR, GLUU, INCY, JNPR, PCRX, SLCA, VCLK)

ThinkstockActive traders and more active investors looking for news lists of stocks to buy or other investing ideas often look…

Jon C. Ogg | Feb 28, 2013 at 12:50 PM EST

ETF Folly: Biotech ETFs, Nothing but Confusion

Thinkstock24/7 Wall St. has always wondered about the confusing universe of biotech exchange-traded funds (ETFs). Biotech stocks can rise or…

Paul Ausick | Jan 23, 2013 at 4:05 PM EST

24/7 Wall St. Closing Bell — January 23, 2013: Market Open Higher on Little News (COST, GE, VZ, F, INCY, AMD, CSX, GOOG, IBM, IGT, TXN, ABT, BHI, COH, GD, MCD, LCC, AAPL, AMGN, NFLX, SNDK, FFIV, NE, NVR, WDC, MMM, BMY, LMT, RYN, LUV, UNP, UAL, XRX, MAPP, AGN, NMRX, MCP)

U.S. equity markets opened higher this morning following a string of solid earnings reports yesterday and after markets closed last…

1 … 6 7 8 9 10

Incyte : INCY

All Incyte Articles

Top Analyst Upgrades and Downgrades: LinkedIn, Safeway, NII Holdings, Rangold, EP Energy and More

Short Sellers Shy Away From Biotechs

Merck Earnings Fail to Dazzle, but the Company’s Story Remains Strong

UBS Says Buy Top Biotech Stocks in Front of Earnings for Big Upside

UBS Has Nine Biotech Buyout and Merger Candidates

J.P. Morgan Top Biotechnology Stocks to Buy for 2014

Solid Biotech Stocks With the Best Revenue Growth for 2014

Jefferies Top Biotech Stocks to Buy

Wednesday Closing Bell: Markets Open, Close Lower

Which Biotech Stocks Are Buyout Targets After Onyx Pharmaceutical Rejects Amgen?

Closing Bell for Tuesday on Wall Street: Share Prices Push Indexes to All-Time Highs

Top Wall Street Analyst Downgrades: AIG, Coach, J.C. Penney and More

7 Active Trading Big Volume Spikes (CHTR, GLUU, INCY, JNPR, PCRX, SLCA, VCLK)

ETF Folly: Biotech ETFs, Nothing but Confusion

24/7 Wall St. Closing Bell — January 23, 2013: Market Open Higher on Little News (COST, GE, VZ, F, INCY, AMD, CSX, GOOG, IBM, IGT, TXN, ABT, BHI, COH, GD, MCD, LCC, AAPL, AMGN, NFLX, SNDK, FFIV, NE, NVR, WDC, MMM, BMY, LMT, RYN, LUV, UNP, UAL, XRX, MAPP, AGN, NMRX, MCP)

Live Nasdaq Composite: Markets Pivot From Headlines to Q2 Earnings, Chip Stock Momentum

XRP Whale Deposits to Binance Just Hit a 2-Month Low: What’s Going On?

Jim Cramer Says Buy Lyft at $15, But Warns AST SpaceMobile Is “Losing a Fortune” and Could Fall to $40

SK Hynix’s HBM Empire Powers 65% US Revenue — Is This the Must-Own AI Stock?

He Cashed Out His Bitcoin at 68 to Play It Safe. Medicare Read It as a Six-Figure Raise.

Is Your Bicentennial Quarter Worth $19,200 or 25 Cents? Here's How to Tell in 10 Seconds

AST SpaceMobile Catapults 12%, SpaceX Rises 7%, Virgin Galactic and Rocket Lab Rally as Space Stock Trade Takes a Risk-on Turn

GE Vernova: The Hidden AI Play That Has Few Growth Headwinds

Incyte : INCY

All Incyte Articles

Top Analyst Upgrades and Downgrades: LinkedIn, Safeway, NII Holdings, Rangold, EP Energy and More

Short Sellers Shy Away From Biotechs

Merck Earnings Fail to Dazzle, but the Company’s Story Remains Strong

UBS Says Buy Top Biotech Stocks in Front of Earnings for Big Upside

UBS Has Nine Biotech Buyout and Merger Candidates

J.P. Morgan Top Biotechnology Stocks to Buy for 2014

Solid Biotech Stocks With the Best Revenue Growth for 2014

Jefferies Top Biotech Stocks to Buy

Wednesday Closing Bell: Markets Open, Close Lower

Which Biotech Stocks Are Buyout Targets After Onyx Pharmaceutical Rejects Amgen?

Closing Bell for Tuesday on Wall Street: Share Prices Push Indexes to All-Time Highs

Top Wall Street Analyst Downgrades: AIG, Coach, J.C. Penney and More

7 Active Trading Big Volume Spikes (CHTR, GLUU, INCY, JNPR, PCRX, SLCA, VCLK)

ETF Folly: Biotech ETFs, Nothing but Confusion

24/7 Wall St. Closing Bell — January 23, 2013: Market Open Higher on Little News (COST, GE, VZ, F, INCY, AMD, CSX, GOOG, IBM, IGT, TXN, ABT, BHI, COH, GD, MCD, LCC, AAPL, AMGN, NFLX, SNDK, FFIV, NE, NVR, WDC, MMM, BMY, LMT, RYN, LUV, UNP, UAL, XRX, MAPP, AGN, NMRX, MCP)

Live Nasdaq Composite: Markets Pivot From Headlines to Q2 Earnings, Chip Stock Momentum

XRP Whale Deposits to Binance Just Hit a 2-Month Low: What’s Going On?

Jim Cramer Says Buy Lyft at $15, But Warns AST SpaceMobile Is “Losing a Fortune” and Could Fall to $40

SK Hynix’s HBM Empire Powers 65% US Revenue — Is This the Must-Own AI Stock?

Featured Reads

He Cashed Out His Bitcoin at 68 to Play It Safe. Medicare Read It as a Six-Figure Raise.

Is Your Bicentennial Quarter Worth $19,200 or 25 Cents? Here's How to Tell in 10 Seconds